These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30942452)

  • 1. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.
    Huang K; Zeng Y; Xie Y; Huang L; Wu Y
    Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
    He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
    Cai Y; Wu D; Zhan L
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
    Peng S; Yu J; Wang Y
    Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
    Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
    Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro.
    Zeng W; Wu M; Cheng Y; Liu L; Han Y; Xie Q; Li J; Wei L; Fang Y; Chen Y; Peng J; Shen A
    PLoS One; 2022; 17(12):e0279851. PubMed ID: 36584147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
    Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
    J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
    Zhang T; Shi W; Tian K; Kong Y
    World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
    Ying Z; Tian H; Li Y; Lian R; Li W; Wu S; Zhang HZ; Wu J; Liu L; Song J; Guan H; Cai J; Zhu X; Li J; Li M
    J Clin Invest; 2017 May; 127(5):1725-1740. PubMed ID: 28375158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCT6A and CHCHD2 Are Coamplified with EGFR and Associated with the Unfavorable Clinical Outcomes of Lung Adenocarcinoma.
    Wang H; Wang X; Xu L; Lin Y; Zhang J
    Dis Markers; 2022; 2022():1560199. PubMed ID: 35937942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status.
    Zhang H; Zheng T; Qin C; Zhang X; Lin H; Huang X; Liu Q; Chang S; Zhang L; Guo J; Zhang Y; Bian C; Liu H
    Cancer Gene Ther; 2024 Aug; 31(8):1151-1163. PubMed ID: 38997438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CCT6A mRNA in chicken granulosa cells is regulated by progesterone.
    Wei Q; Zhu G; Cui X; Kang L; Cao D; Jiang Y
    Gen Comp Endocrinol; 2013 Aug; 189():15-23. PubMed ID: 23644154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
    Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
    Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperonin-Containing TCP1 Subunit 6A Is a Prognostic Potential Biomarker That Correlates With the Presence of Immune Infiltrates in Colorectal Cancer.
    Sun H; Wang Y; Jing HY; Yang XY; Shi XX; Zhang JH; Yu YX; Gao L; Wang XY; Li WH; Yu L
    Front Genet; 2021; 12():629856. PubMed ID: 34017352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB2 increases the proliferation and invasiveness of colon cancer cells through the upregulation of CCT6A.
    Yang X; Tong Y; Ye W; Chen L
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35315492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
    Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
    Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
    Peng W; Li W; Zhang X; Cen W; Liu Y
    J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.